However, when RA is unavailable, or cells become resistant to RA, RARα activation occurs via Erα receptors, thus triggering cell proliferation and tumor metastasis in breast cancer progression (Rossetti et al., 2016). The gene discussed is RARA; the disease is breast carcinoma.